Latest Diabetes management Stories
User Demand for Dario(TM) Demonstrated with Purchase Orders, Positive Initial Customer Feedback and Initial Revenue Generated CAESAREA, Israel, June 17, 2014 /PRNewswire/ -- LabStyle Innovations
According to new research, the symptoms of depression among people with type 2 diabetes can significantly be reduced by interventions for “diabetes distress.”
AWARD-2: Once-Weekly Dulaglutide 0.75 mg Non-Inferior, 1.5 mg Superior in HbA1c Reduction from Baseline with Sustained Weight Loss and Lower Risk for Hypoglycemia SAN FRANCISCO, June 16, 2014
Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development.
Phase 3 Study Results Also Demonstrate INVOKANA® Reduces Secondary Endpoints of Body Weight and Systolic Blood Pressure RARITAN, N.J., June 16, 2014 /PRNewswire/ -- Janssen Research &
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA® (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo.
-- In a two-year study, empagliflozin as add-on to metformin demonstrated significantly greater decreases in A1C (blood glucose), body weight and blood pressure compared with glimepiride as add-on
A team of Massachusetts researchers working on a bionic pancreas were able to show that their device could maintain blood glucose levels consistently within the normal range, with fewer dangerous lows or highs
Algorithm in Development Maintained Glucose Above Hypoglycemic Levels Over 99% of Time in Feasibility Study CHESTERBROOK, Pa., June 16, 2014 /PRNewswire/ --
Up to 2.25 percentage point reduction in HbA1c achieved after only 13 weeks of dosing CARLSBAD, Calif., June 16, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....
- To fire mitraille at.